Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof
The present invention relates to a novel use of NCKAP1 gene in neurodegenerative diseases. More specifically, the present invention relates to a marker composition for predicting the prognosis of a neurodegenerative disease, comprising a NCKAP1 protein or a gene encoding same, a composition and a ki...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Nahm, Min Yeop Lee, Soo Jung Kwon, Min Soo Noh, Min Young Kim, Seung Hyun Oh, Ki Wook |
| description | The present invention relates to a novel use of NCKAP1 gene in neurodegenerative diseases. More specifically, the present invention relates to a marker composition for predicting the prognosis of a neurodegenerative disease, comprising a NCKAP1 protein or a gene encoding same, a composition and a kit for predicting the prognosis of a neurodegenerative disease, which comprises a formulation for measuring the level of the protein or an mRNA of the gene encoding same, and a pharmaceutical composition for preventing or treating neurodegenerative disease, comprising the protein or the gene encoding same as an active ingredient. The pharmaceutical composition comprising the NCKAP1 protein or the gene encoding the same, according to the present invention, can selectively control only specific signal transduction related to the phagocytosis of microglial cells unlike conventional therapeutic agents that induce immunosuppression, and thus can be usefully used for the development of therapeutic agents with high safety and efficiency, and the NCKAP1 protein or the gene encoding the same may be usefully utilized, as a marker for predicting the prognosis of a neurodegenerative disease, for predicting a disease progression rate and treatment outcome. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11958885B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11958885B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11958885B23</originalsourceid><addsrcrecordid>eNqNjr1Ow1AMRrMwoMI7mK0dOgRUKYyhKkICKkRhrqwbJ7nSzfWV7Q59Tl4Il7-ZydKxv-PvvPp4Jhu5U-hZoCMjmWKOeQAEwRI7KMKDkGrk7MQIuAecjmzCZYwBkjPBBBoSCWtUmLdPuwVg7sBzxnKylREHDkfzQH_IwU42F00xuD5FBBtJyMlBv59v149LVOUQ3f_VwihmqGHum_alXvwh740Zptdt-yu5qM56TEqXP3NWXd1v3tYPSyq8Jy0YKJPt33d1fbtqmmZ1d33zn5tP_QdmeQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof</title><source>esp@cenet</source><creator>Nahm, Min Yeop ; Lee, Soo Jung ; Kwon, Min Soo ; Noh, Min Young ; Kim, Seung Hyun ; Oh, Ki Wook</creator><creatorcontrib>Nahm, Min Yeop ; Lee, Soo Jung ; Kwon, Min Soo ; Noh, Min Young ; Kim, Seung Hyun ; Oh, Ki Wook</creatorcontrib><description>The present invention relates to a novel use of NCKAP1 gene in neurodegenerative diseases. More specifically, the present invention relates to a marker composition for predicting the prognosis of a neurodegenerative disease, comprising a NCKAP1 protein or a gene encoding same, a composition and a kit for predicting the prognosis of a neurodegenerative disease, which comprises a formulation for measuring the level of the protein or an mRNA of the gene encoding same, and a pharmaceutical composition for preventing or treating neurodegenerative disease, comprising the protein or the gene encoding same as an active ingredient. The pharmaceutical composition comprising the NCKAP1 protein or the gene encoding the same, according to the present invention, can selectively control only specific signal transduction related to the phagocytosis of microglial cells unlike conventional therapeutic agents that induce immunosuppression, and thus can be usefully used for the development of therapeutic agents with high safety and efficiency, and the NCKAP1 protein or the gene encoding the same may be usefully utilized, as a marker for predicting the prognosis of a neurodegenerative disease, for predicting a disease progression rate and treatment outcome.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240416&DB=EPODOC&CC=US&NR=11958885B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240416&DB=EPODOC&CC=US&NR=11958885B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Nahm, Min Yeop</creatorcontrib><creatorcontrib>Lee, Soo Jung</creatorcontrib><creatorcontrib>Kwon, Min Soo</creatorcontrib><creatorcontrib>Noh, Min Young</creatorcontrib><creatorcontrib>Kim, Seung Hyun</creatorcontrib><creatorcontrib>Oh, Ki Wook</creatorcontrib><title>Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof</title><description>The present invention relates to a novel use of NCKAP1 gene in neurodegenerative diseases. More specifically, the present invention relates to a marker composition for predicting the prognosis of a neurodegenerative disease, comprising a NCKAP1 protein or a gene encoding same, a composition and a kit for predicting the prognosis of a neurodegenerative disease, which comprises a formulation for measuring the level of the protein or an mRNA of the gene encoding same, and a pharmaceutical composition for preventing or treating neurodegenerative disease, comprising the protein or the gene encoding same as an active ingredient. The pharmaceutical composition comprising the NCKAP1 protein or the gene encoding the same, according to the present invention, can selectively control only specific signal transduction related to the phagocytosis of microglial cells unlike conventional therapeutic agents that induce immunosuppression, and thus can be usefully used for the development of therapeutic agents with high safety and efficiency, and the NCKAP1 protein or the gene encoding the same may be usefully utilized, as a marker for predicting the prognosis of a neurodegenerative disease, for predicting a disease progression rate and treatment outcome.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjr1Ow1AMRrMwoMI7mK0dOgRUKYyhKkICKkRhrqwbJ7nSzfWV7Q59Tl4Il7-ZydKxv-PvvPp4Jhu5U-hZoCMjmWKOeQAEwRI7KMKDkGrk7MQIuAecjmzCZYwBkjPBBBoSCWtUmLdPuwVg7sBzxnKylREHDkfzQH_IwU42F00xuD5FBBtJyMlBv59v149LVOUQ3f_VwihmqGHum_alXvwh740Zptdt-yu5qM56TEqXP3NWXd1v3tYPSyq8Jy0YKJPt33d1fbtqmmZ1d33zn5tP_QdmeQ</recordid><startdate>20240416</startdate><enddate>20240416</enddate><creator>Nahm, Min Yeop</creator><creator>Lee, Soo Jung</creator><creator>Kwon, Min Soo</creator><creator>Noh, Min Young</creator><creator>Kim, Seung Hyun</creator><creator>Oh, Ki Wook</creator><scope>EVB</scope></search><sort><creationdate>20240416</creationdate><title>Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof</title><author>Nahm, Min Yeop ; Lee, Soo Jung ; Kwon, Min Soo ; Noh, Min Young ; Kim, Seung Hyun ; Oh, Ki Wook</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11958885B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>Nahm, Min Yeop</creatorcontrib><creatorcontrib>Lee, Soo Jung</creatorcontrib><creatorcontrib>Kwon, Min Soo</creatorcontrib><creatorcontrib>Noh, Min Young</creatorcontrib><creatorcontrib>Kim, Seung Hyun</creatorcontrib><creatorcontrib>Oh, Ki Wook</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Nahm, Min Yeop</au><au>Lee, Soo Jung</au><au>Kwon, Min Soo</au><au>Noh, Min Young</au><au>Kim, Seung Hyun</au><au>Oh, Ki Wook</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof</title><date>2024-04-16</date><risdate>2024</risdate><abstract>The present invention relates to a novel use of NCKAP1 gene in neurodegenerative diseases. More specifically, the present invention relates to a marker composition for predicting the prognosis of a neurodegenerative disease, comprising a NCKAP1 protein or a gene encoding same, a composition and a kit for predicting the prognosis of a neurodegenerative disease, which comprises a formulation for measuring the level of the protein or an mRNA of the gene encoding same, and a pharmaceutical composition for preventing or treating neurodegenerative disease, comprising the protein or the gene encoding same as an active ingredient. The pharmaceutical composition comprising the NCKAP1 protein or the gene encoding the same, according to the present invention, can selectively control only specific signal transduction related to the phagocytosis of microglial cells unlike conventional therapeutic agents that induce immunosuppression, and thus can be usefully used for the development of therapeutic agents with high safety and efficiency, and the NCKAP1 protein or the gene encoding the same may be usefully utilized, as a marker for predicting the prognosis of a neurodegenerative disease, for predicting a disease progression rate and treatment outcome.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US11958885B2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T15%3A57%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Nahm,%20Min%20Yeop&rft.date=2024-04-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11958885B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |